Epithalon: The Longevity Peptide That Activates Telomerase

Epithalon (also spelled Epitalon) is a tetrapeptide — just four amino acids: Ala-Glu-Asp-Gly. Despite its simplicity, it has accumulated more longevity research than almost any other peptide, primarily through the work of Professor Vladimir Khavinson at the Saint Petersburg Institute of Bioregulation and Gerontology over 35 years.

The Telomere Connection

Telomeres are the protective caps at the end of chromosomes. Every time a cell divides, telomeres shorten slightly. When they become critically short, the cell stops dividing — this is cellular senescence, one of the hallmarks of aging. Telomerase is the enzyme that can rebuild and lengthen telomeres.

In 2003, Khavinson et al. demonstrated that Epithalon activates telomerase in somatic cells and measurably elongates telomeres in human fibroblasts. This was the first demonstration of a peptide achieving this in human cells — and it remains one of very few compounds with this evidence.

Other Documented Effects

• Melatonin regulation — stimulates pineal gland melatonin production, which declines with age. Restoring melatonin rhythms improves sleep quality and circadian regulation.
• Immune modulation — enhances T-cell function and NK cell activity. Relevant for age-related immune decline.
• Cancer inhibition — animal studies show Epithalon significantly reduces tumour incidence and slows tumour growth. Mechanism involves cell cycle regulation.
• Lifespan extension — multiple animal studies show 20–35% lifespan extension. Human equivalent studies are not possible ethically, but the animal data is consistent.
• Antioxidant upregulation — increases superoxide dismutase and glutathione peroxidase activity.

Dosing Protocol

Khavinson's clinical protocols (used in Russian clinics for decades):

• Standard course: 10mg/day subcutaneous injection for 10–20 consecutive days
• Frequency: Once or twice per year
• Timing: Morning injection preferred
• Alternative: 5mg/day for 20 days achieves similar results with lower dose

Why Twice Per Year Is Sufficient

Unlike peptides used for acute injury (daily dosing), Epithalon's mechanism involves activating gene expression changes that persist after the course ends. The telomerase activation and melatonin restoration effects are maintained between courses. More frequent use provides no documented additional benefit.

Safety

Epithalon has been used in clinical settings in Russia for over 20 years. No significant adverse effects have been documented across extensive use. It does not affect hormone production. At 4 amino acids, it is extremely simple and well-tolerated. No drug interactions documented.